Evidence map›Paper›PMID 40739040›Full record

ArticleNature microbiology2025

Multi-proteomic profiling of the varicella-zoster virus-host interface reveals host susceptibilities to severe infection.

Virginie Girault, Alexey Stukalov, Madalina Elena Carter-Timofte, Jonny Hertzog, Melissa Verin, Katharina Austen, Darya A Haas, Lila Oubraham, Antonio Piras, Susanne Maidl and 8 more

Abstract read
In one paragraph

Article in Nature microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Virginie GiraultInstitute of Virology, School of Medicine and Health, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-3240-4400
Alexey StukalovInstitute of Virology, School of Medicine and Health, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-4981-8124
Madalina Elena Carter-TimofteDepartment of Infectious Diseases, Aarhus University Hospital (AUH), Aarhus, Denmark.
Jonny HertzogMedical Research Council Human Immunology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Melissa VerinInstitute of Virology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Katharina AustenInstitute of Virology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Darya A HaasInstitute of Virology, School of Medicine and Health, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0001-5543-4875
Lila OubrahamInstitute of Virology, School of Medicine and Health, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-9991-5336
Antonio PirasInstitute of Virology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Susanne MaidlInstitute of Virology, School of Medicine and Health, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0009-0003-5683-1786
Rupert ÖllingerInstitute of Molecular Oncology and Functional Genomics and Department of Medicine II, School of Medicine, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-2292-5982
Roland RadInstitute of Molecular Oncology and Functional Genomics and Department of Medicine II, School of Medicine, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-6849-9659
Ulrike ProtzerInstitute of Virology, School of Medicine and Health, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-9421-1911
Benedikt B KauferInstitute of Virology, Department of Veterinary Medicine at the Freie Universität Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0003-1328-2695
Robert J LebbinkDepartment of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands.ORCID http://orcid.org/0000-0002-1981-0420
Jan RehwinkelMedical Research Council Human Immunology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Trine H MogensenDepartment of Infectious Diseases, Aarhus University Hospital (AUH), Aarhus, Denmark.ORCID http://orcid.org/0000-0002-1853-9704
Andreas PichlmairInstitute of Virology, School of Medicine and Health, Technical University of Munich, Munich, Germany. andreas.pichlmair@tum.de.ORCID http://orcid.org/0000-0002-0166-1367

Funding

Danmarks Grundforskningsfond (Danish National Research Foundation) DNRF 164; CiViADet Frie Forskningsråd (Danish Council for Independent Research) 0134-00006BDeutsche Forschungsgemeinschaft (German Research Foundation) TRR179/TP11; TRR237/A07; TRR353/B04Deutsche Forschungsgemeinschaft (German Research Foundation) TRR179/TP14EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) ERC-CoG 2302 ProDAP, 817798)EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) ERC-CoG ENDo-HERPES,101087480EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) MSCA-ITN GA 2299 675278 EDGEHelmholtz Association KA1-Co-02, COVIPARCUK | Medical Research Council (MRC) 100954/Z/13/ZWellcome TrustWellcome Trust (Wellcome) 100954/Z/13/Z
6 · The paper itself

Abstract

Varicella-zoster virus (VZV) infects most humans and causes chickenpox, shingles and central nervous system pathologies. The molecular basis for these phenotypes remains elusive. Here we conducted a multi-proteomic survey on 64 individual VZV proteins and infection-induced perturbations in a neuronal cell line, identifying 900 interactors and 3,618 regulated host proteins. Data integration suggested molecular functions of viral proteins, such as a mechanism for the ORF61-mediated IFI16 degradation via the recruitment of E3 ligase co-factors. Moreover, we identified proviral host factors (MPP8 and ZNF280D) as potential targets to limit infection. Integration of exome sequencing analysis from patients with VZV-associated central nervous system pathologies identified nephrocystin 4 as a viral restriction factor, and its S862N variant, which showed reduced activity and decreased binding to the regulatory proteins 14-3-3. Collectively, our study provides a comprehensive herpesvirus-host interface resource, which aids our understanding of disease-associated molecular perturbations and data-driven identification of antiviral treatment options.

Indexed as

Herpesvirus 3, HumanHost-Pathogen InteractionsProteomicsVaricella Zoster Virus InfectionCell LineChickenpoxDisease SusceptibilityHumansViral ProteinsViral Proteins

Identifiers

PMID40739040
PMCPMC12313529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.